Indiana 2022 Regular Session Status: In Committee Bipartisan · 1 R · 1 D cosponsors

SB 243 — Prior authorization for addiction treatment.

Last action — Senator Randolph added as coauthor

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2022 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Provides that Medicaid, a policy of accident and sickness insurance, and a health maintenance organization contract may not require prior authorization for a non-opioid prescription drug that is approved by the federal Food and Drug Administration for opioid withdrawal symptoms.

Bill Text

We don't have the full text on file for this bill yet.

Read SB 243 on the official Indiana source →

Action History

  1. Senator Randolph added as coauthor

  2. Senator Zay added as second author

  3. Senator Bohacek added as author

  4. Senator Walker K removed as author

  5. First reading: referred to Committee on Insurance and Financial Institutions

  6. Authored by Senator Walker K

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

2 sponsors · 1 co-sponsors · 147 not signed on

Sponsors (2)

Co-sponsors (1)

Not signed on (147)

147 members have not signed on to this bill.

Show all 147 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 243 do?
Provides that Medicaid, a policy of accident and sickness insurance, and a health maintenance organization contract may not require prior authorization for a non-opioid prescription drug that is approved by the federal Food and Drug Administration for opioid withdrawal symptoms.
Who sponsors SB 243?
SB 243 is sponsored by Mike Bohacek (Republican), Andy Zay, and Lonnie Randolph (Democrat).
What is the current status of SB 243?
This bill died with 2022 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 243?
Track SB 243 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 243

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 243

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →